Article Per Year (5 Year)
p-Index From 2021 - 2026
0.444
P-Index
This Author published in this journals
All Journal Jurnal Pengabdian Pada Masyarakat Indonesian Health Journal
Marcha Debby Saraswati
Universitas Airlangga
Agriculture, Biological Sciences & Forestry Decision Sciences, Operations Research & Management Dentistry Education Engineering Health Professions Medicine & Pharmacology Nursing Public Health Veterinary Other

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Pemberdayaan Pasien dan Keluarga Pasien dalam Pencegahan Amputasi Penderita Diabetes di Kecamatan Mulyorejo Kota Surabaya, Jawa Timur Anggraini Dwi Sensusiati; Budi Suprapti; Marcha Debby Saraswati
Jurnal Pengabdian Pada Masyarakat Vol 6 No 4 (2021)
Publisher : Universitas Mathla'ul Anwar Banten

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30653/002.202164.849

Abstract

EMPOWERMENT OF PATIENTS AND PATIENT FAMILIES IN PREVENTION OF AMPUTATION OF DIABETES IN MULYOREJO DISTRICT, SURABAYA CITY, EAST JAVA PROVINCE. The purpose of implementing this community service program is to empower the community, especially patients and families of diabetes patients, to be able to take steps to prevent disability in diabetes due to amputation. The number of people with diabetes who have to undergo amputation is often influenced by the poor knowledge of diabetes, the low adherence to taking medication, and the poor knowledge and ability of patients and their families in performing wound care for diabetics. In addition, the lack of understanding of diabetes drugs causes the patient to experience side effects that can lead to withdrawal or the patient to experience side effects of hypoglycemia which can put the patient in critical condition. The solution to this problem is to empower diabetes patients and their families. They were given education about diabetes, the importance of taking the medication regularly according to doctor's recommendations, and wound care. In addition, they will be trained on how to do proper wound care for diabetes patients. A medication control post-program will be implemented to ensure that patients will take their medication according to the prescribed guidelines. It is hoped that with this program, the community will understand more about diabetes and its complications to avoiding the disabilities due to amputation by diabetics and patients can avoid unwanted side effects.
Drug Utilization of Statin Therapy in Patients with Acute Coronary Syndrome at the Cardiology and Cardiovascular Outpatient Clinic of Airlangga University Hospital Eunike Christiane Hartanto; Deny Wilson Amanda Sitorus; Wenny Putri Nilamsari; Budi Susetyo Pikir; Marcha Debby Saraswati
Indonesian Health Journal Vol. 5 No. 3 (2026): Indonesian Health Journal
Publisher : Riviera Publishing

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58344/ihj.v5i3.921

Abstract

Acute coronary syndrome (ACS) remains a major cause of cardiovascular morbidity and mortality, and intensive low-density lipoprotein cholesterol (LDL-C) reduction with high-intensity statin therapy is essential for secondary prevention. This study aimed to evaluate statin utilization, treatment appropriateness, drug-related problems, and LDL-C target attainment among patients with ACS. A retrospective observational study was conducted at the Cardiology and Cardiovascular Outpatient Clinic of Universitas Airlangga Hospital, Surabaya, Indonesia. Medical records of patients treated from July to December 2023 were reviewed, and 51 eligible patients receiving statin therapy were included using total sampling. Data were analyzed descriptively. Moderate-intensity statins predominated; simvastatin 20 mg was the most frequently prescribed statin during the first month, whereas atorvastatin 20 mg predominated during the second month, while atorvastatin 40 mg use remained limited. Inappropriate statin therapy was identified in 45 patients (88.24%), including inadequate statin intensity and insufficient treatment duration. Only two patients (3.9%) achieved the recommended LDL-C target of ?55 mg/dL, both after receiving atorvastatin 40 mg. Suspected statin-associated muscle symptoms occurred in four patients (7.84%), while several potential drug–drug interactions were documented. These findings demonstrated that statin therapy for secondary prevention remained suboptimal, highlighting the need for guideline-concordant prescribing, regular LDL-C monitoring, and systematic management of identified drug-related problems.
Co-Authors Budi Suprapti Budi Susetyo Pikir Deny Wilson Amanda Sitorus Eunike Christiane Hartanto Sensusiati, Anggraini Dwi Wenny Putri Nilamsari